Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

Similar articles for PubMed (Select 15765441)

1.

Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers.

Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF, Chow WH.

Clin Gastroenterol Hepatol. 2005 Mar;3(3):225-30.

PMID:
15765441
2.

Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.

Sundelöf M, Lagergren J, Ye W.

Eur J Cancer. 2008 Jul;44(11):1566-71. doi: 10.1016/j.ejca.2008.04.002. Epub 2008 Apr 22.

PMID:
18434132
3.

Population attributable risks of esophageal and gastric cancers.

Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF Jr.

J Natl Cancer Inst. 2003 Sep 17;95(18):1404-13.

4.

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr.

J Natl Cancer Inst. 1998 Jan 21;90(2):150-5.

5.

The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival.

Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC; Australian Cancer Study Clinical Follow-Up Study.

Int J Cancer. 2012 Sep 1;131(5):E759-68. doi: 10.1002/ijc.27420. Epub 2012 Feb 28.

PMID:
22213172
6.

Nutrient intake and risk of subtypes of esophageal and gastric cancer.

Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1055-62.

7.

Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).

González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M, Carneiro F, Nesi G, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Day NE, Linseisen J, Nagel G, Bergmann MM, Overvad K, Jensen MK, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Ocke M, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Psaltopoulou T, Roukos D, Lund E, Hemon B, Kaaks R, Norat T, Riboli E.

J Natl Cancer Inst. 2006 Mar 1;98(5):345-54.

8.

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr.

J Natl Cancer Inst. 1997 Sep 3;89(17):1277-84.

9.

Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Lagergren J, Bergström R, Nyrén O.

Ann Intern Med. 1999 Jun 1;130(11):883-90.

PMID:
10375336
10.

Family history of cancer and risk of esophageal and gastric cancers in the United States.

Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

Int J Cancer. 2001 Jul 1;93(1):148-52.

PMID:
11391635
11.

Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer.

Navarro Silvera SA, Mayne ST, Risch HA, Gammon MD, Vaughan T, Chow WH, Dubin JA, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ.

Ann Epidemiol. 2011 Jul;21(7):543-50. doi: 10.1016/j.annepidem.2010.11.019. Epub 2011 Mar 23.

12.

Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Gockel I, Kneist W, Junginger T.

World J Surg. 2006 Feb;30(2):183-90.

PMID:
16425075
13.
14.

Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.

Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749-56.

15.
16.

Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia.

Sundelöf M, Lagergren J, Ye W.

World J Surg. 2008 Nov;32(11):2357-65. doi: 10.1007/s00268-008-9698-2.

PMID:
18716831
17.

Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study.

Gammon MD, Terry MB, Arber N, Chow WH, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Rotterdam H, West AB, Fraumeni JF Jr, Weinstein IB, Hibshoosh H.

Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):34-9.

18.

Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer.

Morgan MA, Lewis WG, Hopper AN, Escofet X, Harvard TJ, Brewster AE, Crosby TD, Roberts SA, Clark GW.

Dis Esophagus. 2007;20(1):29-35.

PMID:
17227307
19.

Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study.

Sjöberg T, García Rodríguez LA, Lindblad M.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1160-1166.e1.

PMID:
17916544
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk